Tangka Parranthi “Sparking Hope” – Another successful ANZCHOG Annual Scientific Meeting
More than 350 delegates came together recently to attend the ANZCHOG 2024 Annual Scientific Meeting (ASM) in Adelaide (Tarntanya).
ANZCHOG welcomes four new Life Members
At this year’s Annual Scientific Meeting Gala Dinner, four pioneers of childhood cancer treatments received ANZCHOG Life Membership.
A promising advancement for New Zealand children and adolescents with cancer
In positive news for New Zealand children and adolescents with cancer, the ZERO2 study has opened at Starship Children’s Hospital, Auckland.
Management of children with DIPG: ANZCHOG Position Statement
The ANZCHOG Central Nervous System (CNS) Tumour Group has recently published a position statement for the management of children with Diffuse Intrinsic Pontine Glioma (DIPG) in Australia and New Zealand.
Perth Children’s Hospital Opens New Clinical Trial for Children and Adolescents with Ewing Sarcoma
On the eve of Sarcoma and Bone Cancer Awareness Month, Perth Children’s Hospital has become the first international site outside of the United Kingdom to open an innovative clinical trial for children and adolescents with newly diagnosed Ewing Sarcoma.
Oncology Nursing Month – Meet Rachel Edwards
As Oncology Nursing Month comes to a close, we chatted with Rachel Edwards, a paediatric oncology research nurse, member of ANZCHOG’s Board of Directors and member of ANZCHOG’s Nursing Committee.
Celebrating International Nurses Day
To celebrate the contribution nurses make within our community, we spoke with Chris Williams about his role as Regional Nurse Educator & Service Improvement Lead with the Victorian Paediatric Integrated Cancer Service (PICS).
Interfant-21 Opens at First Australian Site
Earlier this week, Perth Children’s Hospital became the first Australian site to open Interfant-21, an international phase 3 clinical trial.